Lawrence S
Curr Res Microb Sci. 2024; 7:100257.
PMID: 39070527
PMC: 11276932.
DOI: 10.1016/j.crmicr.2024.100257.
Berg C, Rosenkilde M
Front Immunol. 2023; 14:1135280.
PMID: 36860859
PMC: 9968965.
DOI: 10.3389/fimmu.2023.1135280.
Rzepka M, Depka D, Gospodarek-Komkowska E, Bogiel T
Pathogens. 2022; 11(11).
PMID: 36422636
PMC: 9697577.
DOI: 10.3390/pathogens11111384.
Zdziarski P, Gamian A
Int J Mol Sci. 2022; 23(17).
PMID: 36076989
PMC: 9455616.
DOI: 10.3390/ijms23179595.
Holtappels R, Podlech J, Freitag K, Lemmermann N, Reddehase M
Viruses. 2022; 14(6).
PMID: 35746617
PMC: 9229300.
DOI: 10.3390/v14061145.
Viral Proteins with PxxP and PY Motifs May Play a Role in Multiple Sclerosis.
Pi K, Sang Y, Straus S
Viruses. 2022; 14(2).
PMID: 35215874
PMC: 8879583.
DOI: 10.3390/v14020281.
Cytomegalovirus reactivation in esophageal cancer patients receiving chemoradiotherapy: A retrospective analysis.
Kitagawa K, Okada H, Miyazaki S, Funakoshi Y, Sanada Y, Chayahara N
Cancer Med. 2021; 10(21):7525-7533.
PMID: 34514723
PMC: 8559503.
DOI: 10.1002/cam4.4269.
Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies.
De Groof T, Elder E, Lim E, Heukers R, Bergkamp N, Groves I
Nat Commun. 2021; 12(1):4436.
PMID: 34290252
PMC: 8295288.
DOI: 10.1038/s41467-021-24608-5.
Pathogenesis of human cytomegalovirus in the immunocompromised host.
Griffiths P, Reeves M
Nat Rev Microbiol. 2021; 19(12):759-773.
PMID: 34168328
PMC: 8223196.
DOI: 10.1038/s41579-021-00582-z.
Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art.
Esposito S, Chiopris G, Messina G, DAlvano T, Perrone S, Principi N
Vaccines (Basel). 2021; 9(5).
PMID: 34069321
PMC: 8158681.
DOI: 10.3390/vaccines9050523.
HCMV Antivirals and Strategies to Target the Latent Reservoir.
Perera M, Wills M, Sinclair J
Viruses. 2021; 13(5).
PMID: 34062863
PMC: 8147263.
DOI: 10.3390/v13050817.
Human Cytomegalovirus miR-US25-1 Targets the GTPase RhoA To Inhibit CD34 Hematopoietic Progenitor Cell Proliferation To Maintain the Latent Viral Genome.
Diggins N, Crawford L, Hancock M, Mitchell J, Nelson J
mBio. 2021; 12(2).
PMID: 33824207
PMC: 8092260.
DOI: 10.1128/mBio.00621-21.
Validation of Preamplification to Improve Quantification of Cytomegalovirus DNA Using Droplet Digital Polymerase Chain Reaction.
Zhang W, Bream J, Leng S, Margolick J
Anal Chem. 2021; 93(8):3710-3716.
PMID: 33596050
PMC: 10074994.
DOI: 10.1021/acs.analchem.0c02890.
Profiling the Blood Compartment of Hematopoietic Stem Cell Transplant Patients During Human Cytomegalovirus Reactivation.
Bernshtein B, Nachshon A, Shnayder M, Stern L, Avdic S, Blyth E
Front Cell Infect Microbiol. 2021; 10:607470.
PMID: 33489936
PMC: 7820775.
DOI: 10.3389/fcimb.2020.607470.
CD34 Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.
Crawford L, Hancock M, Struthers H, Streblow D, Yurochko A, Caposio P
J Virol. 2020; 95(3).
PMID: 33177198
PMC: 7925096.
DOI: 10.1128/JVI.02105-20.
Regulation of the MIE Locus During HCMV Latency and Reactivation.
Dooley A, OConnor C
Pathogens. 2020; 9(11).
PMID: 33113934
PMC: 7690695.
DOI: 10.3390/pathogens9110869.
Human Cytomegalovirus Interleukin 10 Homologs: Facing the Immune System.
Poole E, Neves T, Oliveira M, Sinclair J, Carlan da Silva M
Front Cell Infect Microbiol. 2020; 10:245.
PMID: 32582563
PMC: 7296156.
DOI: 10.3389/fcimb.2020.00245.
Cytomegaloviruses and Macrophages-Friends and Foes From Early on?.
Baasch S, Ruzsics Z, Henneke P
Front Immunol. 2020; 11:793.
PMID: 32477336
PMC: 7235172.
DOI: 10.3389/fimmu.2020.00793.
Where do we Stand after Decades of Studying Human Cytomegalovirus?.
Gugliesi F, Coscia A, Griffante G, Galitska G, Pasquero S, Albano C
Microorganisms. 2020; 8(5).
PMID: 32397070
PMC: 7284540.
DOI: 10.3390/microorganisms8050685.
Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine Development.
Gerna G, Lilleri D
Vaccines (Basel). 2020; 8(2).
PMID: 32340180
PMC: 7349293.
DOI: 10.3390/vaccines8020194.